Subscribe
shutterstock_723369586_phushutter
Phushutter / Shutterstock.com
23 April 2019Big Pharma

Hologics and Grifols agree $14m Enzo settlement

Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and  Grifols, ending a patent dispute between the parties.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
The importance of Minerva Surgical v Hologic
2 February 2021   A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.
Americas
US government urges SCOTUS to deny retroactive IPR suit
13 May 2020   The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.
Americas
Uni of South Florida researchers accuse Hologic of patent infringement
12 March 2020   The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
The importance of Minerva Surgical v Hologic
2 February 2021   A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.
Americas
US government urges SCOTUS to deny retroactive IPR suit
13 May 2020   The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.
Americas
Uni of South Florida researchers accuse Hologic of patent infringement
12 March 2020   The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.

More on this story

Big Pharma
The importance of Minerva Surgical v Hologic
2 February 2021   A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.
Americas
US government urges SCOTUS to deny retroactive IPR suit
13 May 2020   The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.
Americas
Uni of South Florida researchers accuse Hologic of patent infringement
12 March 2020   The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB